Operating

Other Working Capital

Kailera Therapeutics Other Working Capital increased by 171.4% to $19.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.

Detailed definition

Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...

Peer comparison

Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.

Metric ID: change_in_other_working_capital

Historical Data

2 periods
 Q1 '25Q1 '26
Value$7.00K$19.00K
QoQ Change—+171.4%
YoY Change—+171.4%
Range$7.00K – $19.00K
Avg YoY Growth+171.4%
Median YoY Growth+171.4%

Other Working Capital at Other Companies

Darden Restaurants logo
Darden RestaurantsDRIView metric
Marriott International logo
Marriott InternationalMARView metric
Brookfield Asset Management logo
Brookfield Asset ManagementBAMView metric
Otis Worldwide logo
Otis WorldwideOTISView metric
CBRE Group logo
CBRE GroupCBREView metric
Valero Energy logo
Valero EnergyVLOView metric

Frequently Asked Questions

What is Kailera Therapeutics 's other working capital?
Kailera Therapeutics (KLRA) reported other working capital of $19.00K in Q1 2026.
What does other working capital mean?
Net cash impact from changes in miscellaneous operating assets and liabilities.